• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, May 26, 2017

Article

Coverage of our peer-reviewed research in the healthcare and mainstream press.

An article on PatientEngagementHIT.com reported on the findings of a study published in the May 2017 issue of The American Journal of Managed Care® (AJMC®). In “The Association of Mental Health Program Characteristics and Patient Satisfaction,” researchers explored whether veterans’ satisfaction with care was linked with modifiable measures of mental health program reach, service access, program intensity, and treatment continuity. They found positive associations for some of the variables, which could lead to the use of administrative data as a patient satisfaction measure, according to the PatientEngagementHIT.com story.

A VentureBeat article reporting on a startup that will offer virtual reality treatment for stroke victims explained the economic costs of strokes, using data from AJMC® research. The 2010 article, “US Cost Burden of Ischemic Stroke: A Systematic Literature Review,” estimated that nearly 800,000 Americans experience a stroke each year, resulting in direct and indirect costs of over $65 billion.

AJMC® coverage of the recent ISPOR meeting was highlighted in several daily e-newsletters from the National Pharmaceutical Council. The Tuesday e-mail included an article reporting on a session about incorporating stakeholder preferences into value assessments. The Wednesday e-mail featured a video interview with Ilene Hollin, PhD, MPH, who explained how a tailored approach to value assessment is necessary for innovation.

Related Videos
Will Shapiro
Patrick Vermersch, MD, PhD
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.